换一批摘要This article reviews the interactions between gut microbiota and cancer immunotherapies and discusses microbiota-based patient stratification strategies such as the prediction of response and the early recognition of toxic events.Additionally,it explores the emerging potential of microbiotherapy to enhance anti-neoplastic efficacy and alleviate toxicity,with the ultimate goal of developing personalized treatment regimens for patients with hepatocellular carcinoma(HCC).
更多相关知识
栏目名称
DOI
10.20517/2394-5079.2024.76
发布时间
2025-01-17（万方平台首次上网日期，不代表论文的发表时间）
- 浏览5
- 被引0
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
